Uridine phosphorylase: Difference between revisions
CSV import |
CSV import |
||
| (One intermediate revision by the same user not shown) | |||
| Line 35: | Line 35: | ||
[[Category:Cancer therapy]] | [[Category:Cancer therapy]] | ||
[[Category:Hereditary disorders]] | [[Category:Hereditary disorders]] | ||
__NOINDEX__ | |||
{{No image}} | |||
__NOINDEX__ | __NOINDEX__ | ||
Latest revision as of 02:37, 18 March 2025
Uridine phosphorylase is an enzyme that plays a crucial role in the metabolism of nucleotides. It is responsible for the breakdown of uridine into uracil and ribose-1-phosphate. This enzyme is found in various organisms, including bacteria, plants, and animals. In humans, uridine phosphorylase is encoded by the UP gene.
Function[edit]
Uridine phosphorylase is an essential enzyme in the salvage pathway of nucleotide metabolism. It catalyzes the reversible phosphorolysis of uridine, resulting in the release of uracil and ribose-1-phosphate. This reaction allows the recycling of uridine and the generation of ribose-1-phosphate, which can be utilized in the synthesis of nucleotides.
Structure[edit]
Uridine phosphorylase is a homodimeric enzyme, meaning it consists of two identical subunits. Each subunit contains a catalytic site responsible for the enzymatic activity. The active site of uridine phosphorylase contains a conserved histidine residue that acts as a nucleophile during the phosphorolysis reaction.
Role in Nucleotide Metabolism[edit]
Uridine phosphorylase is involved in the metabolism of pyrimidine nucleotides. It is responsible for the breakdown of uridine, a pyrimidine nucleoside, into uracil and ribose-1-phosphate. The released uracil can be further metabolized to produce other pyrimidine nucleotides, while ribose-1-phosphate can be utilized in the synthesis of nucleotides or other cellular processes.
Clinical Significance[edit]
Uridine phosphorylase has been implicated in various diseases and conditions. For example, deficiencies in this enzyme have been associated with hereditary pyrimidine nucleoside phosphorylase (PNP) deficiency, a rare autosomal recessive disorder characterized by immunodeficiency, neurologic abnormalities, and developmental delay. Additionally, uridine phosphorylase has been explored as a potential target for cancer therapy, as its inhibition can lead to the accumulation of toxic nucleoside analogs in cancer cells.
References[edit]
<references />
See Also[edit]